Upload Avatar (500 x 500)
Yong Chu
cy110@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 1998/09-2001/12 Ph.D.: Sichuan University, West China School of Pharmacy
  • 1995/09-1998/08 Master's: Kunming Institute of Precious Metals
  • 1991/09-1995/07 Bachelor's: Xihua Normal University, Department of Chemistry
  • Published over 30 papers in domestic and international academic journals
  • Applied for over 20 Chinese invention patents, 8 authorized, 1 US patent application
  • Co-authored 2 textbooks
  • 2014/12-Present - Fudan University, School of Pharmacy, Department of Medicinal Chemistry - Associate Professor
  • 2019 - Shanghai Drug Evaluation and Inspection Center - External Expert
  • 2015-2017 - National Medical Products Administration, Center for Drug Evaluation - Drug Reviewer (Secondment)
  • 2006/03-2014/12 - Fudan University, School of Pharmacy, Department of Medicinal Chemistry - Lecturer
  • 2008/01-2009/02 - Georgia State University, Department of Chemistry - Postdoctoral Researcher
  • 2004/08-2006/02 - Basilea Pharmaceutica (China) Ltd., Chemistry Department - R&D Team Leader
  • 2002/06-2004/07 - Fudan University, Department of Chemistry - Postdoctoral Researcher
Target-based original small molecule drug discovery
Research on therapeutic drugs for neurodegenerative diseases and development of imaging diagnostic probes
  • Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β), Yang Gao, Peng Zhang, Anfeng Cui, De-Yong Ye, Meng Xiang, Yong Chu, 2018
  • The discovery of novel benzothiazinones as highly selective non-ATP competitive glycogen synthase kinase 3β inhibitors for the treatment of ovarian cancer, Yang Gao, Deyong Ye, Wei-cheng Zhou, Yong Chu, 2017
  • An efficient one-pot procedure for the synthesis of 1,5-benzothiazepinones catalyzed by tetrabutylammonium fluoride (TBAF), Zhang, Peng, Ye, Deyong, Chu, Yong, 2016
  • Novel Benzothiazinones (BTOs) as Allosteric Modulator or Substrate Competitive Inhibitor of Glycogen Synthase Kinase 3β (GSK-3β) with Cellular Activity of Promoting Glucose Uptake, Peng Zhang, Shufen Li, Yang Gao, Wenbo Lu, Ke Huang, De-Yong Ye, Xi Li, Yong Chu, 2014
  • Design, Synthesis and Biological Evaluation of Benzothiazepinones (BTZs) as Novel Non-ATP Competitive Inhibitors of Glycogen Synthase Kinase-3β (GSK-3β), Peng Zhang, Hai-Rong Hu, Shi-Hui Bian, Zhao-Hui Huang, Yong Chu, De-Yong Ye, 2013
  • Fluorescent conjugate of sLex-selective bisboronic acid for imaging application, Yong Chu, Danzhu Wang, Ke Wang, Zhiren (Luis) Liu, Brent Weston, Binghe Wang, 2013
  • Identification of Novel Scaffold of Benzothiazepinones as Non-ATP Competitive Glycogen Synthase Kinase-3β Inhibitors through Virtual Screening, Peng Zhang, Hai-Rong Hu, Zhao-Hui Huang, Jia-Yi Lei, Yong Chu, De-Yong Ye, 2012
  • Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase, Kaiqing Ma, Penghui Wang, Wei Fu, Xiaolong Wan, Yong Chu, Deyong Ye, 2011
  • Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen, Chaofeng Dai, Lisa H. Cazares, Lifang Wang, Yong Chu, Siming L. Wang, Dean A. Troyer, O. John Semmes, Richard R. Drake, Binghe Wang, 2011
Drug Discovery Small Molecules Neurodegenerative Diseases Imaging Probes Gsk-3Β Inhibitors Pet Tracers Protein Modulators Nmr Imaging Agents Fluorescent Probes Molecular Design

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.